Anemia in patients with tumors of the female reproductive system
Objective: to assess the efficacy of Sideral forte (combination of sucrosomial iron and vitamin C) in the treatment of iron deficiency anemia in patients with tumors of the female reproductive system.Materials and methods. The study included 35 patients with benign tumors of the female reproductive...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2019-11-01
|
Series: | Опухоли женской репродуктивной системы |
Subjects: | |
Online Access: | https://ojrs.abvpress.ru/ojrs/article/view/660 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1839570930432475136 |
---|---|
author | A. G. Kedrova T. A. Greyan N. S. Vanke S. E. Krasilnikovт |
author_facet | A. G. Kedrova T. A. Greyan N. S. Vanke S. E. Krasilnikovт |
author_sort | A. G. Kedrova |
collection | DOAJ |
description | Objective: to assess the efficacy of Sideral forte (combination of sucrosomial iron and vitamin C) in the treatment of iron deficiency anemia in patients with tumors of the female reproductive system.Materials and methods. The study included 35 patients with benign tumors of the female reproductive system and 27 patients with cancer; all of them were also diagnosed with grade I iron deficiency anemia. The duration of therapy with Sideral forte at a dose of 1 capsule per day varied between 30 and 60 days. We evaluated frequency and intensity of clinical and hematological response to treatment, as well as drug tolerability.Results. Therapy with Sideral forte ensured improvement of blood parameters in both patient groups. All participants received the drug during 8 weeks; it was well tolerated, demonstrated no side effects, and did not cause gastrointestinal disorders. The increase in the level of hemoglobin was observed in both groups; however, cancer patients had less pronounced dynamics.Conclusions. Sideral forte is an effective oral drug that can be used for the treatment of iron deficiency anemia in patients with tumors of the female reproductive system. |
format | Article |
id | doaj-art-81c77a72e26f4a2ca4fb5f85fd6e26f8 |
institution | Matheson Library |
issn | 1994-4098 1999-8627 |
language | Russian |
publishDate | 2019-11-01 |
publisher | ABV-press |
record_format | Article |
series | Опухоли женской репродуктивной системы |
spelling | doaj-art-81c77a72e26f4a2ca4fb5f85fd6e26f82025-08-04T14:33:41ZrusABV-pressОпухоли женской репродуктивной системы1994-40981999-86272019-11-01153313610.17650/1994-4098-2019-15-3-31-36620Anemia in patients with tumors of the female reproductive systemA. G. Kedrova0T. A. Greyan1N. S. Vanke2S. E. Krasilnikovт3Federal Scientific and Clinical Center for Specialized Medical Assistance and Medical Technologies of the Federal Medical Biological Agency of Russia; Academy of Postgraduate Education under the Federal Scientific and Clinical Center for Specialized Medical Assistance and Medical Technologies of the Federal Medical Biological Agency of RussiaAcademy of Postgraduate Education under the Federal Scientific and Clinical Center for Specialized Medical Assistance and Medical Technologies of the Federal Medical Biological Agency of RussiaFederal Scientific and Clinical Center for Specialized Medical Assistance and Medical Technologies of the Federal Medical Biological Agency of Russia; Academy of Postgraduate Education under the Federal Scientific and Clinical Center for Specialized Medical Assistance and Medical Technologies of the Federal Medical Biological Agency of RussiaNovosibirsk Regional Clinical Narcology DispensaryObjective: to assess the efficacy of Sideral forte (combination of sucrosomial iron and vitamin C) in the treatment of iron deficiency anemia in patients with tumors of the female reproductive system.Materials and methods. The study included 35 patients with benign tumors of the female reproductive system and 27 patients with cancer; all of them were also diagnosed with grade I iron deficiency anemia. The duration of therapy with Sideral forte at a dose of 1 capsule per day varied between 30 and 60 days. We evaluated frequency and intensity of clinical and hematological response to treatment, as well as drug tolerability.Results. Therapy with Sideral forte ensured improvement of blood parameters in both patient groups. All participants received the drug during 8 weeks; it was well tolerated, demonstrated no side effects, and did not cause gastrointestinal disorders. The increase in the level of hemoglobin was observed in both groups; however, cancer patients had less pronounced dynamics.Conclusions. Sideral forte is an effective oral drug that can be used for the treatment of iron deficiency anemia in patients with tumors of the female reproductive system.https://ojrs.abvpress.ru/ojrs/article/view/660anemic syndromeiron deficiency anemiauterine tumorsovarian tumors |
spellingShingle | A. G. Kedrova T. A. Greyan N. S. Vanke S. E. Krasilnikovт Anemia in patients with tumors of the female reproductive system Опухоли женской репродуктивной системы anemic syndrome iron deficiency anemia uterine tumors ovarian tumors |
title | Anemia in patients with tumors of the female reproductive system |
title_full | Anemia in patients with tumors of the female reproductive system |
title_fullStr | Anemia in patients with tumors of the female reproductive system |
title_full_unstemmed | Anemia in patients with tumors of the female reproductive system |
title_short | Anemia in patients with tumors of the female reproductive system |
title_sort | anemia in patients with tumors of the female reproductive system |
topic | anemic syndrome iron deficiency anemia uterine tumors ovarian tumors |
url | https://ojrs.abvpress.ru/ojrs/article/view/660 |
work_keys_str_mv | AT agkedrova anemiainpatientswithtumorsofthefemalereproductivesystem AT tagreyan anemiainpatientswithtumorsofthefemalereproductivesystem AT nsvanke anemiainpatientswithtumorsofthefemalereproductivesystem AT sekrasilnikovt anemiainpatientswithtumorsofthefemalereproductivesystem |